Compared with early-HCC, LC, CH, and NHS group, the titer of autoantibodies against GRP78 in early stage of HCC, LC, and CH groups were significantly higher than controls (Figure 2B). The gene discussed is HSPA5; the disease is hepatocellular carcinoma.